Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

23 Oct 2008 07:00

RNS Number : 4896G
Alumasc Group PLC
22 October 2008
 



Thursday 23 October 2008

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

Continued good performance

Alumasc (ALU.L), the premium building and engineering products company, is holding its Annual General Meeting at 10.30 a.m. today and is publishing its first interim management statement relating to the year ending 30 June 2009.

 

As predicted in the preliminary announcement of 10 September 2008, Alumasc has continued to perform well. First quarter revenue and profits are both ahead of prior period comparators1, benefiting from further growth in demand for sustainable building products. 

First quarter revenue in the Building Products division, representing almost 70% of group revenue, grew by 8%, or 6% on a like-for-like basis. This growth was driven by a 12% like-for-like increase in revenue from sustainable building products, with Levolux, in particular, recording another strong performance. Whilst contraction in UK house building activity dampened overall growth rates, this sector now accounts for less than 7% of group revenue. Rapid management action has been taken to reduce costs in areas where demand has fallen.

First quarter revenue in the Engineering Products division, representing just over 30% of group revenue, was ahead by almost 10%, reflecting a better start to the current year at Alumasc Precision Components, where steady progress is being made in rebuilding profitability. There are early signs of some softening in demand for automotive work and at Alumasc Dispense, albeit together these represent less than one-third of divisional revenues.

Group operating margins were similar to prior period levels. Whilst Building Products' divisional margins experienced some erosion from changes in product mix across our business portfolio and from the appreciation of the Euro and Dollar against Sterling, Engineering Products' margins have shown some improvement from low levels in the prior year's first quarter

There have been no significant changes to trading trends since 30 September 2008 and no significant changes in the group balance sheet since the group's 30 June 2008 year end. Group net debt has remained broadly unchanged from the £9.4 million reported at the year end, with gearing levels comfortable at around 30%.

We continue actively to seek and analyse opportunities for developing our portfolio of sustainable building product businesses further where market prospects remain attractive. 

As with many businesses commenting in recent weeks, we see a marked difference between our own performance and the intense financial troubles which surround us. Alumasc's order books and balance sheet remain strong, placing the group in a good position to deal with the current economic uncertainties.

Note 1: Prior period profit has been re-stated in respect of Alumasc Precision Components, for the reasons described on page 34 of the group's 2008 Annual Report.

Enquiries:

The Alumasc Group plc
 
Paul Hooper (Group Chief Executive)
 Tel: 01536 383821
Andrew Magson (Group Finance Director)
 Tel: 01536 383844
 
 
Bankside Consultants
 
Charles Ponsonby
 Tel: 0207 367 8851
Rose Oddy
 Tel: 0207 367 8853

This interim management statement has been drawn up and presented for the purposes of complying with English law. Any liability arising out of or in connection with this interim management statement will also be determined in accordance with English law.

This interim management statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors beyond the group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

Nothing in this interim management statement is intended to be a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQLLFLVBBFFBK
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.